GleamWall
中文EN

ELV Elevance Health, Inc.

Hospital & Medical Service Plans · NYSE · SEC CIK 1156039 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY3.6%
TTM net income YoY-7.1%
TTM EPS YoY-4.0%
Revenue 3-yr CAGR6.2%
Net income 3-yr CAGR-5.0%

Margins

Gross margin—
Operating margin2.7%
Net margin2.5%
FCF margin3.2%
EBITDA margin3.4%

Returns

ROE11.6%
ROA4.1%
ROIC (approx.)6.7%
Asset turnover1.61x

Leverage & solvency

Liabilities / assets65.0%
Debt / equity0.69x
Current ratio1.47x
Interest coverage3.76x

Cash quality & payout

Operating cash flow / net income1.48x
Accruals ratio-2.0%
Payout ratio29.2%
Capex / revenue0.5%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$51.43B$50.47B$50.18B$49.75B$50.71B$49.78B$48.89B$45.44B
Cost of revenue$5.64B$5.49B$5.46B$5.52B$5.38B$5.29B$4.98B$6.01B
SG&A expense$5.75B$5.55B$6.33B$5.42B$5.27B$5.00B$5.30B$4.80B
Operating income$1.27B$1.76B$2.09B$309.00M$1.29B$2.42B$3.17B$673.00M
Interest expense$358.00M$364.00M$357.00M$366.00M$351.00M$341.00M$344.00M$340.00M
Pretax income$1.79B$1.94B$2.30B$215.00M$1.41B$2.29B$2.80B$606.00M
Income tax$451.00M$483.00M$544.00M-$331.00M$219.00M$548.00M$613.00M$193.00M
Net income$1.36B$1.46B$1.76B$547.00M$1.19B$1.74B$2.18B$418.00M
EBITDA$1.63B$2.13B$2.44B$715.00M$1.68B$2.81B$3.54B$1.07B
EPS (basic)6.306.748.03—5.327.749.64—
EPS (diluted)6.276.718.00—5.327.729.61—
Dividends declared per share1.721.721.721.711.711.711.711.63
Weighted avg. shares (diluted)217.60M217.90M220.40M—223.70M225.80M227.20M—
Balance sheet
Cash & equivalents$10.35B$10.23B$9.66B$9.49B$8.71B$8.56B$7.50B$8.29B
Short-term investments$25.35B$25.72B$25.91B$25.88B$26.28B$25.30B$25.44B$25.20B
Current assets$68.52B$67.18B$67.03B$63.00B$63.78B$63.32B$61.12B$58.94B
PP&E, net$4.61B$4.64B$4.66B$4.68B$4.66B$4.64B$4.62B$4.65B
Goodwill$28.34B$28.34B$28.34B$28.34B$28.45B$28.37B$28.42B$28.28B
Intangibles$10.88B$10.98B$11.09B$11.20B$11.33B$11.49B$11.94B$12.09B
Total assets$127.80B$126.44B$125.83B$121.49B$122.75B$121.94B$119.72B$116.89B
Current liabilities$46.66B$44.25B$45.31B$41.03B$40.88B$43.83B$42.70B$40.58B
Short-term debt$375.00M$375.00M$350.00M$1.10B$749.00M$1.65B$1.64B$1.65B
Long-term debt$30.38B$30.67B$30.77B$30.80B$31.17B$28.18B$28.11B$29.22B
Total debt$30.76B$31.04B$31.12B$31.90B$31.92B$29.83B$29.75B$30.87B
Total liabilities$83.01B$81.42B$81.78B$77.47B$78.67B$78.09B$77.10B$75.46B
Shareholders' equity$44.68B$44.88B$43.90B$43.88B$43.95B$43.72B$42.50B$41.31B
Net debt$20.41B$20.81B$21.46B$22.41B$23.21B$21.27B$22.25B$22.58B
Shares outstanding216.11M216.84M217.37M220.72M222.04M224.84M225.64M227.48M
Cash flow statement
Operating cash flow$1.27B$1.91B$4.33B$84.00M$1.14B$2.05B$1.02B$706.00M
Capital expenditure$267.00M$287.00M$235.00M$293.00M$360.00M$267.00M$196.00M$322.00M
Free cash flow$1.00B$1.63B$4.10B-$209.00M$775.00M$1.79B$821.00M$384.00M
Investing cash flow-$1.99B$159.00M-$1.64B$464.00M-$1.22B-$687.00M$103.00M-$1.64B
Financing cash flow$838.00M-$1.49B-$2.52B$236.00M$243.00M-$308.00M-$1.91B$1.41B
Depreciation & amortization$363.00M$366.00M$354.00M$406.00M$387.00M$380.00M$373.00M$398.00M
Stock-based compensation$80.00M$75.00M$55.00M$30.00M$84.00M$81.00M$81.00M-$29.00M
Dividends paid$373.00M$373.00M$376.00M$377.00M$381.00M$385.00M$386.00M$373.00M
Share buybacks$330.00M$234.00M$1.12B$471.00M$876.00M$378.00M$880.00M$1.81B

Free plan shows the latest 8 periods; Pro shows all 74 🔒

· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.